LL

Lakshmikanthan Lavanya

Director DIN 03494935
DIN 03494935 First appointment Apr 2011
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Lakshmikanthan Lavanya

Data last updated:

Lakshmikanthan Lavanya was a Director at Art Biotech Private Limited (from 2016) and Director at Reproductive Technologies India Private Limited (from 2011).

DIN 03494935
First Appointment 18 Apr 2011
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Art Biotech Private Limited U33119TN2016PTC112980
Director19 Oct 20162016₹4.18 Cr (FY 2018)Strike Off
Director18 Apr 20112011₹3.13 Cr (FY 2016)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Art Biotech Private Limited
Reproductive Technologies India Private Limited
Premium access

Shareholding and investment profile for Lakshmikanthan Lavanya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lakshmikanthan Lavanya

Lakshmikanthan Lavanya was first appointed on 18 Apr 2011 as Director at Reproductive Technologies India Private Limited. The most recent appointment on record is 19 Oct 2016 at Art Biotech Private Limited.

Lakshmikanthan Lavanya held 2 earlier board appointments: Art Biotech Private Limited (Director, from 19 Oct 2016); Reproductive Technologies India Private Limited (Director, from 18 Apr 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available